Author: PatientsCann UK

PatientsCann UK Appointed UK Representative to IACM Patients Council

Empowering Patients Worldwide We are thrilled to announce a significant milestone for PatientsCann UK – our appointment as the UK representative to the International Alliance for Cannabinoid Medicines (IACM) Patients Council. This prestigious position marks a new chapter in our commitment to advocating for patient rights and fostering collaboration on a global scale. About IACM Patients Council The IACM Patients Council is a dynamic coalition of patient organisations from around the world. Its primary objective is to provide a unified voice for patients in the rapidly evolving landscape of medicinal cannabis. By working collectively, these organisations aim to safeguard the rights and interests of patients and ensure their perspectives are integral to the ongoing developments in medicinal cannabis. Our Role as the UK Representative As the UK representative to the IACM Patients Council, PatientsCann is honoured to take on the responsibility of championing the concerns, aspirations, and needs of patients in the United Kingdom. This role aligns seamlessly with our core mission of promoting a patient-centric approach to medical cannabis advocacy. Key Focus Areas Global Collaboration: We look forward to actively engaging with patient organisations worldwide. By fostering international collaboration, we can share insights, best practices, and advocate for the common goal of improving patient access and rights. Information Exchange: Our role involves facilitating the exchange of information between patients, organisations, and key stakeholders. By doing so, we aim to contribute to the creation of a well-informed and empowered patient community. Advocacy and Education: Through our representation, we will advocate for policies that prioritise patient well-being. Education will be a focal point, ensuring that patients are equipped with the knowledge to make informed decisions about their healthcare. PatientsCann’s Commitment Our journey with the IACM Patients Council is not just about representation; it’s about effecting positive change. PatientsCann is committed to leveraging this opportunity to enhance the dialogue surrounding medicinal cannabis, challenge stigmas, and drive initiatives that benefit patients globally. We express our gratitude to our supporters, volunteers, and the entire medical cannabis community. Your encouragement has been instrumental in reaching this milestone. Together, let’s continue advancing patient-centric approaches to medical cannabis and shaping a more compassionate and informed world. Empowering Patients, Transforming Lives.

PatientsCann UK Joins Forces with the NCVO: Elevating Medical Cannabis Advocacy

We are thrilled to share some exciting news! PatientsCann UK is a proud member of the National Council for Voluntary Organisations (NCVO). This is a significant step forward in our journey of advocating for patient rights and fostering positive change in the medical cannabis landscape. Understanding the NCVO: The NCVO is a leading voice for the voluntary sector in the UK. Established in 1919, NCVO champions the work of charities, community groups, and voluntary organisations, providing them with a platform to collectively address challenges and amplify their impact. This membership places PatientsCann in a vibrant network of over 15,000 member organisations, ranging from small community groups to well-established charities. The Value of NCVO Membership for PatientsCann: Networking and Collaboration: Joining NCVO opens doors to a diverse community of organisations working towards social change. This network provides opportunities for collaboration, knowledge sharing, and building alliances within and beyond the medical cannabis sector. Advocacy Amplification: NCVO is a powerful advocate for the voluntary sector, influencing policies and decisions at the national level. By aligning with NCVO, PatientsCann gains a stronger voice in shaping policies that directly impact medical cannabis patients and the industry. Capacity Building: NCVO offers a wealth of resources, training, and support to enhance the effectiveness and impact of voluntary organisations. This invaluable support will empower PatientsCann to further its mission of educating, advocating, and supporting the medical cannabis community. Policy Engagement: As an NCVO member, PatientsCann gains access to valuable insights on policy developments and changes affecting the voluntary sector. This knowledge is crucial for steering our advocacy efforts in a rapidly evolving medical cannabis landscape. Implications for the Medical Cannabis Community: Our membership with NCVO is not just a milestone for PatientsCann; it’s a win for the entire medical cannabis community. It elevates the visibility of medical cannabis advocacy within broader discussions on healthcare, patient rights, and social well-being. Looking Ahead: As we embark on this exciting journey with the NCVO, we are filled with gratitude for the continued support of our community. Together, we will continue to strive for a future where medical cannabis patients are informed, empowered, and treated with the dignity they deserve. Stay tuned for more updates, and thank you for being an essential part of the PatientsCann community.

Empowering GPs to ‘Protect our Patients’: Join the Campaign!

https://www.protectourpatients.co.uk/ In the realm of medical cannabis, a significant disparity exists between patients’ needs and their access to appropriate treatments. While progress has been made, with the UK government allowing specialists to prescribe cannabis medicines in 2018, a critical challenge remains: general practitioners (GPs) are still unable to prescribe this potentially life-changing therapy. As a consequence, a staggering 1.8 million individuals in the UK are compelled to turn to the illicit cannabis market for medical reasons. This is further exacerbated by the financial strain faced by those on low incomes, who struggle to afford private prescriptions. It’s high time we address these issues and embark on a transformative journey to protect our patients and enhance healthcare outcomes. The ‘Protect our Patients’ campaign is a groundbreaking initiative aimed at rectifying the inequity surrounding medical cannabis prescriptions. Its core mission is to advocate for GPs to be granted the same prescribing rights as consultants, thus empowering them to effectively support their patients in need. By removing the existing barriers, we can ensure that every individual, regardless of their socioeconomic background, has access to safe and effective cannabis-based treatments. In 2018, the UK government acknowledged the therapeutic potential of cannabis medicines and legalised their prescription. However, this progressive step fell short in one crucial aspect: GPs were excluded from the regulatory framework, limiting their ability to provide comprehensive care to their patients. This oversight has resulted in a significant gap in access to medical cannabis, forcing patients to navigate the illicit market or face financial hardship to obtain private prescriptions. GPs serve as the first point of contact for patients, entrusted with their comprehensive healthcare. By granting them the authority to prescribe cannabis medicines, we open doors to a range of benefits: The time has come to bridge the gap in patient care and advocate for the empowerment of GPs to prescribe medical cannabis. Together, let’s protect our patients and ensure equitable access to life-changing treatments. Visit ProtectOurPatients.co.uk to learn more about the campaign, get involved, and be part

What is Medical Cannabis

Cannabis Based Medical Products (CBMPs) or Medical Cannabis are medications derived from the cannabis plant

Dosing Guidance for Dry Herb Vaporising

Dry herb vaporising offers a precise and efficient way to consume cannabis, allowing users to experience the therapeutic benefits of cannabinoids and terpenes without the potential harms associated with smoking. To ensure a safe and enjoyable vaporising experience, it’s essential to understand the boiling points of various terpenes and cannabinoids and how they impact the effects of cannabis. Importance of Temperature ControlTemperature control is a critical aspect of dry herb vaporising, as different compounds in cannabis vaporise at specific temperatures. By adjusting the temperature, users can target specific cannabinoids and terpenes to customise their experience. Boiling Points of Common Cannabinoids Cannabinoid Boiling Point (°C) THC 157°C CBD 160-180°C CBG 52-65°C CBN 185°C CBC 220°C THCV 220°C Boiling Points of Common Terpenes Terpene Boiling Point (°C) Myrcene 167°C Limonene 176°C Pinene 155°C Linalool 198°C Caryophyllene 130°C Humulene 198°C Terpinolene 185°C Bisabolol 151°C Eucalyptol 176°C Guaiol 167°C Nerolidol 161°C Phytol 160°C Dosage and Temperature Recommendations: Cannabinoid / Terpene Temperature Range (°C) Potential Effects and Benefits THC 157°C Euphoria, Relaxation, Pain Relief CBD 160-180°C Anti-inflammatory, Anxiolytic, Anticonvulsant CBG 52-65°C Neuroprotective, Anti-inflammatory, Potential Antibacterial Effects CBN 185°C Mild Sedation, Potential Sleep Aid CBC 220°C Anti-inflammatory, Potential Antidepressant Effects THCV 220°C Potential Appetite Suppressant, Anticonvulsant Myrcene 167°C Sedating, Relaxing, Potential Anti-inflammatory Effects Limonene 176°C Uplifting, Mood-Enhancing, Potential Antioxidant Effects Pinene 155°C Alertness, Memory Enhancement, Potential Bronchodilator Linalool 198°C Calming, Stress-Reducing, Potential Analgesic Effects Caryophyllene 130°C Anti-inflammatory, Potential Gastro-protective Effects, No Psychoactive effects Humulene 198°C Anti-inflammatory, Potential Appetite Suppressant Terpinolene 185°C Uplifting, Potential Antioxidant and Anticancer Effects Bisabolol 151°C Calming, Potential Anti-inflammatory and Antioxidant Effects Eucalyptol 176°C Potential Anti-inflammatory and Analgesic Effects Guaiol 167°C Potential Anti-inflammatory and Antioxidant Effects Nerolidol 161°C Calming, Potential Sedative and Anti-fungal Effects Phytol 160°C Potential Antioxidant and Anti-inflammatory Effects Dosage RecommendationsDosage for dry herb vaporising depends on several factors, including individual tolerance, desired effects, the potency of the cannabis strain and prescriber’s guidance. Start with a low dose and gradually increase until the desired effects are achieved. Safety ConsiderationsAlways use a reputable vaporiser with accurate temperature controls to ensure precise dosing and avoid combustion. High temperatures (above 230°C) may produce harmful by-products and should be avoided. ConclusionDry herb vaporising provides a customisable and controlled method of cannabis consumption. Understanding the boiling points of cannabinoids and a wide range of terpenes allows users to fine-tune their experience and target specific effects. Start with low temperatures and dosage, gradually increasing as needed, to enjoy the full potential of cannabinoids and terpenes while minimising potential adverse effects. Disclaimer: The information provided in this context is intended for general informational purposes only and should not be construed as medical advice under any circumstances. It is essential to consult with a qualified healthcare professional or medical practitioner before making any decisions or taking any actions related to medical treatment or dosing. The content here does not replace professional medical guidance, and any reliance on the information presented is at your own risk. We strive to maintain accuracy and up-to-date information; however, we do not warrant the completeness, reliability, or validity of the information provided. Therefore, we disclaim any liability for any adverse outcomes or damages arising from the use or misuse of the information mentioned here. Always seek personalised medical advice from a licensed healthcare provider for your specific medical condition or situation.